Answers are grounded in this paper and cite their sources.
Objectives : This retrospective cohort study aimed to investigate the relationship between admission RDW-SD and 1-year COPD-related readmission in patients with AECOPD. Methods : A total of 875 patients with AECOPD admitted to the Second People’s Hospital of Banan District in Chongqing, China, between January 2023 and December 2023 were enrolled. Patients were divided into quartiles according to admission RDW-SD levels. Cox regression models, Kaplan–Meier analysis, and RCS regression were used to evaluate the association. Results : The 1-year COPD-related readmission rate was 34.5% (n = 304). After adjustment for comprehensive confounders, patients in the highest RDW-SD quartile had a 59% higher risk of 1-year readmission compared with those in the lowest quartile (HR = 1.59, 95% CI: 1.11–2.26, P = 0.011). Kaplan–Meier curves revealed that higher RDW-SD was associated with increased readmission risk over follow-up (Log-rank P < 0.001). RCS regression confirmed a linear association between RDW-SD and readmission risk. Subgroup analyses demonstrated that this association remained stable across most subgroups, with only sex showing a significant interaction effect. Conclusion : Our findings indicate that admission RDW-SD is an independent predictor of 1-year COPD-related readmission in patients with AECOPD, with a linear dose-response relationship. This easily accessible biomarker could help clinicians identify high risk patients for targeted post-discharge interventions.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: